Recruiting Clinical Trials

Clinical and Histopathologic Characteristics of BAP1 Mutations

By April 24, 2017 No Comments

Condition

Malignant Pleural Mesothelioma (MPM)|Choroidal Nevus|Primary Uveal Melanoma (UM)|Metastatic Uveal Melanoma (UM)|Renal Cell Carcinoma|Cholangiocarcinoma

Estimated Enrollment: 460

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Observational

Study Design Allocation: Observational Model: Cohort|Time Perspective: Prospective

Study ID Numbers: 12-235

Study First Received: January 18, 2013

Last Updated: January 27, 2017

Estimated Primary Completion Date: January 2018

 

Primary Outcome Measures:

determine the prevalence of germline BAP1 mutations|prevalence of somatic BAP1 mutations in disease mesothelioma and metastatic uveal melanoma.

Sponsors and Collaborators:

Memorial Sloan Kettering Cancer Center|United States Department of Defense

Website Link: https://ClinicalTrials.gov/show/NCT01773655

Leave a Reply

Call Now ButtonCall Now